Cargando…
Novel Selenium-based compounds with therapeutic potential for SOD1-linked amyotrophic lateral sclerosis
BACKGROUND: Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease as well as Lou Gehrig's disease, is a progressive neurological disorder selectively affecting motor neurons with no currently known cure. Around 20% of the familial ALS cases arise from dominant mutations in the...
Autores principales: | Amporndanai, Kangsa, Rogers, Michael, Watanabe, Seiji, Yamanaka, Koji, O'Neill, Paul M., Hasnain, S. Samar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456458/ https://www.ncbi.nlm.nih.gov/pubmed/32862101 http://dx.doi.org/10.1016/j.ebiom.2020.102980 |
Ejemplares similares
-
Intracerebroventricular administration of Cystatin C ameliorates disease in SOD1‐linked amyotrophic lateral sclerosis mice
por: Watanabe, Seiji, et al.
Publicado: (2018) -
Selenium-based compounds: Emerging players in the ever-unfolding story of SOD1 in amyotrophic lateral sclerosis.
por: Yerbury, Justin J., et al.
Publicado: (2020) -
Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons
por: Lasiene, Jurate, et al.
Publicado: (2016) -
SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system
por: Watanabe, Seiji, et al.
Publicado: (2014) -
SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization
por: Banci, Lucia, et al.
Publicado: (2008)